Ultrasound-Enhanced Drug Delivery System with Integrated IoT, AI, and Blockchain Technologies

The inventive concept integrates ultrasound-enhanced drug delivery with IoT, AI, and blockchain technologies to create a more powerful and personalized system for ophthalmic care.

The original patent disclosed a system and method for ultrasound-enhanced delivery of drugs to the intraocular space. However, it had limitations in terms of data analysis, security, and personalization. The new inventive concept addresses these limitations by incorporating IoT, AI, and blockchain technologies to enable real-time monitoring, personalized treatment planning, and secure data storage.

The new system consists of a wearable IoT-enabled device with an integrated ultrasound transducer and a drug applicator. The wearable device transmits data to a remote server for analysis using machine learning algorithms. The analyzed data is stored in a blockchain-based secure data storage system, ensuring data integrity and security. The system generates personalized treatment plans based on the analysis, which are then transmitted to the wearable device for implementation. The system also includes a nanomaterial-based drug applicator with enhanced ultrasound coupling properties, and a signal generating unit operationally connected to the drug applicator, which generates ultrasound waves with optimized frequency and amplitude for the nanomaterial-based drug applicator. Additionally, the system includes a swarm robotics-based drug applicator with multiple ultrasound transducers, enabling synchronized ultrasound waves for enhanced drug delivery.

The new inventive concept is novel and non-obvious compared to the original patent because it integrates distinct technologies such as IoT, AI, and blockchain to create a more powerful and personalized system for ultrasound-enhanced drug delivery. The inventive step lies in the synergistic combination of these technologies to enable real-time monitoring, personalized treatment planning, and secure data storage.

Alternative embodiments of the inventive concept could include using different types of sensors, such as electroencephalography (EEG) or electromyography (EMG), to collect data from the wearable device. The system could also be adapted for use in other medical applications, such as cancer treatment or pain management. Additionally, the blockchain-based secure data storage system could be replaced with other secure data storage solutions, such as homomorphic encryption or secure multi-party computation.

The inventive concept has significant commercial potential in the ophthalmic care industry, particularly in the treatment of diseases such as central retinal vein occlusion (CRVO), branch retinal vein occlusion (BRVO), and age-related macular degeneration (AMD). The system's ability to provide personalized treatment plans and real-time monitoring could improve patient outcomes and reduce healthcare costs. The market for ophthalmic care is growing rapidly, driven by an aging population and increasing prevalence of eye diseases.